4/29/2026CDE Seeks Feedback on Draft Bioanalytical Lab Compliance Report for Cl...

4/29/2026CDE Opens Consultation on BNCT Drug Development Guideline

4/28/2026China Moves to Expand Maternity Insurance Coverage in Draft Healthcare...

4/27/2026China NMPA Releases Updated Procedures for Conditional Drug Approvals

4/24/2026China Seeks Feedback on New Approval Framework for Clinical Translati...

4/24/2026CDE Issues New Framework for Post-Approval Changes and Registration Te...

4/23/2026CDE Issues New Guidance Table on Post-Approval Changes and Triggering ...

4/22/2026CDE Opens Public Consultation on 106th Batch of Reference Formulations...

4/22/2026China Suspends Import and Use of Colchicine API from Two Indian Manufa...

4/22/2026China Unveils Landmark Drug Pricing Framework to Boost Innovation and ...

4/20/2026China Seeks Feedback on ICH M8 eCTD v4.0 Implementation, Advancing Reg...

4/20/2026CDE Issues New Technical Guidelines for IND-Enabling CMC Dossiers Cove...

4/20/2026China Releases 104th Batch of Reference Formulations for Generic Drug ...

4/20/2026China Seeks Public Input on New GSP Appendix for Retail Pharmacy Chain...

4/16/2026China Moves Toward Value-Based Drug Pricing, Granting Greater Autonomy...

4/16/2026China CDE Opens Consultation on Draft CMC Guideline for Therapeutic Bo...

4/14/2026China Unveils New Drug Pricing Reform to Balance Innovation, Affordabi...

4/13/2026China CDE Releases Patient-Centered Clinical Development Guideline for...

4/13/2026China CDE Opens Public Consultation on Draft ARC CMC Guideline

4/10/2026CDE Seeks Comments on New Technical Guideline for Staged Manufacturing...

4/9/2026CDE Releases New Clinical Evaluation Guideline for IND Applications to...

4/9/2026CDE Issues New Clinical Evaluation Guideline for Drug Marketing Applic...

4/8/2026NMPA Adopts ICH M14 Guideline, Expanding China's Regulatory Framework ...

4/8/2026NMPA Adopts ICH Q8, Q9 and Q10 Q&A (R5)

4/3/2026NMPA Suspends Import, Sale and Use of Cadila's Amlodipine Besylate API...

4/3/2026CDE Revises Drug R&D and Technical Review Communication Management Mea...

4/2/2026NMPA Releases Implementation Opinions on "AI + Drug Regulation"

4/2/2026NMPA Issues Notice on Advancing Segmented Manufacturing of Biologics

4/1/2026China CDE Opens Public Consultation on 105th Batch of Chemical Generic...

3/31/2026NMPA Moves to Strengthen China's Conditional Drug Approval Framework

Page:1/9 Total number of articles:245: [First][<<] [1] [2] [3] [4] [5] [>>] [End]